Prostate Cancer

Movember Launches Global Bid to Reduce the Risk of Prostate Cancer Progression November 30, 2021

Sociodemographic and Geographic Disparities of Prostate Cancer Treatment Delay in Tennessee: A Population-Based Study. November 30, 2021

Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients. November 30, 2021

A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies. November 30, 2021

Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis. November 30, 2021

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial. November 30, 2021

Lantheus Announces PYLARIFY AI™ is Now Available November 29, 2021

Lack of Consensus Identifies Important Areas for Future Clinical Research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 Findings November 29, 2021

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer. November 29, 2021

Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy. November 29, 2021

A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease. November 29, 2021

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients. November 29, 2021

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations. November 29, 2021

Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer. November 26, 2021

NUAK family kinase 2 is a novel therapeutic target for prostate cancer. November 26, 2021

National consensus quality indicators to assess quality of care for active surveillance in low-risk prostate cancer: An evidence-informed modified Delphi survey of Canadian urologists/radiation oncologists. November 26, 2021

Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial. November 26, 2021

Clinically Significant Prostate Cancer Detection After A Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI. November 26, 2021

Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context. November 25, 2021

Robotic-assisted radical prostatectomy in young adults: age-stratified oncological and functional outcomes. November 25, 2021

Page 1 of 1189

email news signup